Teriparatide

FDA-approved product existsPeptideRecovery & tissue repair

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is Teriparatide?

FDA-approved teriparatide products exist for specified women and men with osteoporosis at high fracture risk and for glucocorticoid-associated osteoporosis in specified patients.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

Approved labelTeriparatide injection prescribing information for approved osteoporosis indications
PopulationWomen and men covered by the approved teriparatide indications
Dose20 mcg
RouteSubcutaneous injection into the thigh or abdomen
FrequencyOnce daily
DurationUse beyond 2 years during a lifetime is considered only when the patient remains at or returns to high fracture risk
PreparationReady-to-use 560 mcg/2.24 mL solution in a prefilled pen intended to deliver twenty-eight 20 mcg doses; no reconstitution. Discard the pen 28 days after first use.
Source: Dosage and Administration sections 2.1-2.3; Dosage Forms and Strengths section 3

Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalFDA-approved product exists
CompoundingFDA-approved products exist; compounded copies are not FDA approved

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.